Preclinical Imaging (In-VIVO) Market

01

Executive Summary

Global Preclinical Imaging (In-VIVO) Market Size, 2017-2026 (USD Million)

The global preclinical imaging market size is expected to grow from USD 778.1 million in 2020 to USD 1,036.9 million by 2026 at a CAGR of 4.9%.

Many factors such as technological advances in the field of molecular imaging, the growing market demand for non-invasive animal models, and the growing number of private and public programs and funding to support pre-clinical research promote the growth of preclinical global imaging. market. However, factors such as a strong control framework that governs pre-clinical research, as well as significant inclusion and operational costs associated with preclinical imaging strategies are some of the major factors hindering the growth of the preclinical imaging market. In addition, the technical limitations and processes associated with private systems are a major challenge for players in the Preclinical Imaging market.

By product, the global preclinical imaging market is divided into two main categories, namely, modality (optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-Ultrasound systems, micro-CT systems, photoacoustic imaging systems, and magnetic particle imaging systems) and reagents (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents). The modality segment is expected to grow at a higher CAGR over the next five years, due to the widespread use of imaging systems in preclinical research studies worldwide, higher program costs, and the development and marketing of advanced imaging technologies.

Geographically, the preclinical imaging market is divided into five regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. In 2020, the global preclinical imaging market is expected to be dominated by North America. Many factors such as strong R&D infrastructure for health science research, rapid adoption of novel cell imaging technology, the significant presence of pharmaceutical companies and biotechnology, and increased popularity of end-users of multimodality systems drive the growth of the pre-clinical imaging market. North American Region. The Asia-Pacific market is expected to grow with the highest CAGR from 2020 to 2026. This is due to the government's continued support for the R&D of pharmaceutical and biotechnology, which increases private sector investment to support radioisotope production, a growing number of translation research activities, and a growing regulatory environment across major Asian countries.

Some of the major players operating in the global preclinical imaging market are Bruker Corporation (U.S.), PerkinElmer, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Mediso Ltd. (Hungary), Aspect Imaging (Israel), Trifoil Imaging (U.S.) LI-COR Biosciences (U.S.), and Miltenyi Biotec GmbH (Germany).

Revenue Share (%), By Modality (2019)
Revenue Share (%), By Reagent (2019)
Revenue Share (%), By Region (2019)

02

Market Overview

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

03

By Region

By Region, The global Preclinical Imaging (In-VIVO) Market analysis covers Asia-Pacific, Europe, North America, Rest of the World (RoW).

The Asia-Pacific segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Asia-Pacific: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Europe segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Europe: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The North America segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

North America: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Rest of the World (RoW) segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Rest of the World (RoW): global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

04

By Reagent

By Reagent, The global Preclinical Imaging (In-VIVO) Market analysis covers Preclinical CT Contrast Agents, Preclinical MRI Contrast Agents, Preclinical Nuclear Imaging Reagents, Preclinical Optical Imaging Reagents, Preclinical Ultrasound Contrast Agents.

The Preclinical CT Contrast Agents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Preclinical CT Contrast Agents: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Preclinical MRI Contrast Agents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Preclinical MRI Contrast Agents: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Preclinical Nuclear Imaging Reagents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Preclinical Nuclear Imaging Reagents: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Preclinical Optical Imaging Reagents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Preclinical Optical Imaging Reagents: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Preclinical Ultrasound Contrast Agents segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Preclinical Ultrasound Contrast Agents: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

05

By Modality

By Modality, The global Preclinical Imaging (In-VIVO) Market analysis covers Magnetic Particle Imaging (MPI) Systems, Micro-CT, Micro-MRI, Micro-Ultrasound, Nuclear Imaging Systems, Optical Imaging Systems, Photoacoustic Imaging Systems.

The Magnetic Particle Imaging (MPI) Systems segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Magnetic Particle Imaging (MPI) Systems: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Micro-CT segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Micro-CT: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Micro-MRI segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Micro-MRI: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Micro-Ultrasound segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Micro-Ultrasound: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Nuclear Imaging Systems segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Nuclear Imaging Systems: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Optical Imaging Systems segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Optical Imaging Systems: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

The Photoacoustic Imaging Systems segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Photoacoustic Imaging Systems: global Preclinical Imaging (In-VIVO) Market Revenue Opportunity (Us$ Mn)

08

Europe

Based on the Europe, the Preclinical Imaging (In-VIVO) Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Preclinical Imaging (In-VIVO) Size, 2019-2027 (Us$ Mn) — Europe Preclinical Imaging (In-VIVO) Market Size, 2019-2027 (Us$ Mn)

Europe Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Europe Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

Germany Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Germany Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

United Kingdom Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

United Kingdom Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

France Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

France Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

Spain Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Spain Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

Russia Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Russia Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

Italy Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Italy Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

Rest of Europe Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Reagent, 2019-2027

Rest of Europe Preclinical Imaging (In-VIVO) Market - Historical, Forecast Market Sizes (US$ MN), By Modality, 2019-2027

08

Asia-Pacific

Based on the Asia-Pacific, the Preclinical Imaging (In-VIVO) Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.